Testing effectiveness (Phase 2)Study completedNCT02966834
What this trial is testing
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis
Who this might be right for
Cholestasis
GlaxoSmithKline 147